A Single Dose Escalation Study In Healthy Volunteers To Determine The Pharmacokinetics, Safety And Tolerability Of PF-05089771 In Healthy Volunteers

NCT01259882 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: PF-05089771
DRUG: PF-05089771
DRUG: PF-05089771
DRUG: PF-05089771
DRUG: PF-05089771
DRUG: PF-05089771

Sponsor

Pfizer